The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...

Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy: Basel Friday, February 14, 2025, 13:00 Hrs [IST] Roche, announced that the US Food ...

The 5 mg risdiplam tablet provides the same efficacy and safety for spinal muscular atrophy as the currently available oral ...

Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and safety as the currently ...

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

This study presents solid evidence for distinct neurotransmitter release modalities between two subclasses of dopaminergic neurons in the olfactory bulb, highlighting an important finding that ...

Three studies of the brain regions responsible for processing sensory information show that their neurons are and communicate ...

Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...

One Melbourne council is repurposing city footpaths to include designated e-bike and e-scooter parking in a Victorian ...

Nerve Renew is a dietary supplement designed to address neurological problems and restore healthy nerve function. The formula ...

UBC researchers have discovered a new type of neuron that plays a fundamental role in recognition memory—how the brain ...